PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Catterton acquires cosmeceutical brand StriVectin

Catterton Partners, a consumer-focused private equity firm, has acquired the StriVectin brand and related assets from affiliates of Klein-Becker.

Catterton Partners, a consumer-focused private equity firm, has acquired the StriVectin brand and related assets from affiliates of Klein-Becker.

Chrysallis, a management team in the beauty and personal care industry, led by chief executive officer Melisse Shaban and chief marketing officer Jill Scalamandre, will lead the new company.

StriVectin specialises in the global skincare market, which is expected to reach USD58.2bn by 2012, an increase of 17.6 per cent since 2007.

Lauded as the "stretch-mark cream turned anti-wrinkle phenomenon" since being introduced in 2003, StriVectin is the fastest growing anti-aging brand and one of the top 20 prestige skincare brands in the US.

The StriVectin line encompasses a range of anti-aging products, including StriVectin Instant Facial Sculpting Cream, StriVectin-SD Eye Cream, StriVectin Neck Cream, and StriVectin -WF Instant Deep Wrinkle Filler.

StriVectin products are sold through retailers as well as direct marketing channels around the world, with the largest presence in the US, France and the UK.

"The skincare market is no longer about aspirational luxury; it’s about what works and in this regard, we see tremendous value in the StriVectin brand," says Shaban. "StriVectin’s record of profitable growth is a tribute to its customer centric marketing and targeted formulations, which helped create the cosmeceutical skincare category. With this transaction, we intend to build on these strengths and our own expertise to further enhance StriVectin’s product portfolio and extend its global reach. We will be looking at new technologies to strengthen StriVectin’s strong clinical positioning, thereby increasing value to the end consumer.’

Terms of the transaction were not disclosed.

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured